These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24591918)

  • 1. Effect of GnRH analogues and octreotide treatment on apoptosis and the cell proliferation of endometrium adenocarcinoma cell lines.
    Oztürk HB; Vural B; Calışkan E; Solakoğlu S
    J Turk Ger Gynecol Assoc; 2010; 11(3):131-6. PubMed ID: 24591918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of GnRH analogues on apoptosis and expression of Bcl-2, Bax, Fas and FasL proteins in endometrial epithelial cell cultures from patients with endometriosis and controls.
    Bilotas M; Barañao RI; Buquet R; Sueldo C; Tesone M; Meresman G
    Hum Reprod; 2007 Mar; 22(3):644-53. PubMed ID: 17092985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of GnRH analogues on apoptosis and release of interleukin-1beta and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis.
    Meresman GF; Bilotas MA; Lombardi E; Tesone M; Sueldo C; Barañao RI
    Hum Reprod; 2003 Sep; 18(9):1767-71. PubMed ID: 12923126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis.
    Meresman GF; Bilotas M; Buquet RA; Barañao RI; Sueldo C; Tesone M
    Fertil Steril; 2003 Sep; 80 Suppl 2():702-7. PubMed ID: 14505742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do GnRH analogues directly affect human endometrial epithelial cell gene expression?
    Zhang X; Bocca S; Franchi A; Anderson S; Kaur M; Bajic VB; Oehninger S
    Mol Hum Reprod; 2010 May; 16(5):347-60. PubMed ID: 20203127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
    Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
    Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells.
    Luo X; Xu J; Chegini N
    Reprod Biol Endocrinol; 2003 Dec; 1():125. PubMed ID: 14678567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
    Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
    Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
    Zhao LJ; Wei LH; Li XP; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis.
    Tesone M; Bilotas M; Barañao RI; Meresman G
    Gynecol Obstet Invest; 2008; 66 Suppl 1():10-8. PubMed ID: 18936547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
    Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
    Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
    Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells.
    Nagai N; Oshita T; Mukai K; Shiroyama Y; Shigemasa K; Ohama K
    Int J Mol Med; 2002 Nov; 10(5):593-7. PubMed ID: 12373298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of the GnRH type 1 receptor blocks the antiproliferative effect of the GnRH agonist, leuprolide, on the androgen-independent prostate cancer cell line DU145.
    Ko YH; Ha YR; Kim JW; Kang SG; Jang HA; Kang SH; Park HS; Cheon J
    J Int Med Res; 2011; 39(3):729-39. PubMed ID: 21819703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs.
    Pappa EV; Zompra AA; Spyranti Z; Diamantopoulou Z; Pairas G; Lamari FN; Katsoris P; Spyroulias GA; Cordopatis P
    Biopolymers; 2011; 96(3):260-72. PubMed ID: 20632397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
    Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
    Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death.
    Imai A; Takagi A; Horibe S; Takagi H; Tamaya T
    J Clin Endocrinol Metab; 1998 Feb; 83(2):427-31. PubMed ID: 9467552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoperone IN3 enhances the apoptotic effect of leuprolide in prostate cancer cells by increasing the gonadotropin-releasing hormone receptor in the cell membrane.
    Sánchez CA; Mercado AJ; Contreras HR; Cabezas JC; Huidobro CC; Castellón EA
    Anticancer Drugs; 2012 Oct; 23(9):959-69. PubMed ID: 22713594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell growth effects of leuprolide on cultured endometrioma cells.
    Levine D; Kaufman L; Cuenca VG; Badawy SZ
    J Reprod Med; 2007 Jul; 52(7):581-4. PubMed ID: 17847754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.